Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Amneal Pharmaceuticals A | AMRX | Sep 20, 2024 | 8.70 | -1.25 |
Ampco-Pittsburgh | AP | Sep 20, 2024 | 2.11 | -7.86 |
Amphastar Pharmaceuticals | AMPH | Sep 20, 2024 | 49.18 | -1.82 |
Amphenol | APH | Sep 20, 2024 | 65.91 | +0.95 |
Amplify Energy | AMPY | Sep 20, 2024 | 6.65 | -1.19 |
Amplify Online Retail ETF | IBUY | Sep 20, 2024 | 59.01 | -0.66 |
Amplify Transformational Data Sharing ETF | BLOK | Sep 20, 2024 | 36.47 | -0.08 |
Amplitech Group | AMPG | Sep 20, 2024 | 0.76 | -13.99 |
Amplitude A | AMPL | Sep 20, 2024 | 9.05 | 0.00 |
Amprius Technologies | AMPX | Sep 20, 2024 | 0.89 | +1.61 |
AMREP | AXR | Sep 20, 2024 | 29.96 | +6.05 |
AMTD Digital ADR | HKD | Sep 20, 2024 | 2.98 | 0.00 |
AMTD Idea Group ADR | AMTD | Sep 20, 2024 | 1.31 | -4.38 |
Amtech Systems | ASYS | Sep 20, 2024 | 5.96 | -1.89 |
Amylyx Pharmaceuticals | AMLX | Sep 20, 2024 | 3.10 | +7.64 |
AN2 Therapeutics | ANTX | Sep 20, 2024 | 1.05 | -2.78 |
Analog Devices | ADI | Sep 20, 2024 | 226.78 | -2.86 |
AnaptysBio | ANAB | Sep 20, 2024 | 38.48 | +2.53 |
Anavex Life Sciences | AVXL | Sep 20, 2024 | 5.64 | -2.08 |
Andretti Acquisition II Unit | POLEU | Sep 20, 2024 | 9.98 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Sep 20, 2024 | 3.08 | +48.08 |
ANEW Medical | WENA | Sep 20, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Sep 20, 2024 | 13.17 | +0.08 |
Angel Oak Mortgage REIT | AOMR | Sep 20, 2024 | 10.59 | +0.19 |
Anghami | ANGH | Sep 20, 2024 | 0.86 | -1.71 |
Angi A | ANGI | Sep 20, 2024 | 2.88 | +1.41 |
AngioDynamics | ANGO | Sep 20, 2024 | 7.54 | -2.08 |
Anglogold Ashanti | AU | Sep 20, 2024 | 28.03 | +1.63 |
Anheuser-Busch InBev ADR | BUD | Sep 20, 2024 | 63.13 | -1.05 |
ANI Pharmaceuticals | ANIP | Sep 20, 2024 | 59.66 | -1.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.